Content in this website may be linked to, as long as the linking webpage
and passage has a known and clearly stated author.
Is the Rise in RSV Infections Associated With Immune Debt or SARS-CoV-2 Immune Dysfunction?
References:
1. News Release. CDC. Nov. 4, 2022. Accessed on Feb. 10, 2023 from
https://www.cdc.gov/media/releases/2022/t1104-update-respiratory-disease-circulation.html
2. National Center for Educational Statistics (NCES). HealthData.gov.
School Learning in Children. Updated Jan. 6, 2023. Accessed on Feb. 10,
2023 from
https://healthdata.gov/National/School-Learning-Modalities/aitj-yx37
3. Clarke KEN, Jones JM, Deng Y, et al. Seroprevalence of
Infection-Induced SARS-CoV-2 Antibodies — United States, September
2021–February 2022. MMWR Morb Mortal Wkly Rep. 2022 Apr
29;71(17):606-608. doi: 10.15585/mmwr.mm7117e3.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098232/
4. Jia R, Lu L, Su L, et al. Resurgence of Respiratory Syncytial Virus
Infection During COVID-19 Pandemic Among Children in Shanghai, China.
Front Microbiol. 2022 Jul 1;13:938372. doi: 10.3389/fmicb.2022.938372.
eCollection 2022. Accessed on Feb. 10, 2023 from
https://www.frontiersin.org/articles/10.3389/fmicb.2022.938372/full
5. Wang L, Davis PB, Berger NA, et al. Disruption in seasonality,
patient characteristics and disparities of respiratory syncytial virus
infection among young children in the US during and before the COVID-19
pandemic: 2010-2022. medRxiv. Nov. 29, 2022. Accessed on Feb. 10, 2023
from
https://pubmed.ncbi.nlm.nih.gov/36482981/
6. Mizrahi B, Sudry T, Flaks-Manov N, et al. Long covid outcomes at one
year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023
Jan 11;380:e072529. doi: 10.1136/bmj-2022-072529.: Accessed on Feb. 10,
2023 from
https://doi.org/10.1136/bmj-2022-072529
7. Phetsouphanh, C., Darley, D.R., Wilson, D.B. et al. Immunological
dysfunction persists for 8 months following initial mild-to-moderate
SARS-CoV-2 infection. Nat Immunol. 2022 Feb;23(2):210-216. doi:
10.1038/s41590-021-01113-x. Epub 2022 Jan 13. Accessed on Feb. 10, 2023
from
https://doi.org/10.1038/s41590-021-01113-x
8. Shen, XR., Geng, R., Li, Q. et al. ACE2-independent infection of T
lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022 Mar
11;7(1):83. doi: 10.1038/s41392-022-00919-x. Accessed on Feb. 10, 2023
from
https://doi.org/10.1038/s41392-022-00919-x
9. Khoo WH, Jackson K, Phetsouphanh C, et al. Tracking the clonal
dynamics of SARS-CoV-2-specific T cells in children and adults with
mild/asymptomatic COVID-19. Clin Immunol. 2023 Jan;246:109209. doi:
10.1016/j.clim.2022.109209. Epub 2022 Dec 17. Accessed on Feb. 10, 2023
from
https://www.sciencedirect.com/science/article/pii/S152166162200290X
10. Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae
associated with SARS-CoV-2 reinfection. Nat Med. 2022
Nov;28(11):2398-2405. doi: 10.1038/s41591-022-02051-3. Epub 2022 Nov 10.
Accessed on Feb. 10, 2023 from
https://doi.org/10.1038/s41591-022-02051-3
11. RSV National Trends. The National Respiratory and Enteric Virus
Surveillance System (NREVSS) Centers for Disease Control and Prevention.
https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html
12. Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease
Group (GPIP) position paper on the immune debt of the COVID-19 pandemic
in childhood, how can we fill the immunity gap? Infectious Diseases Now.
Aug. 2021.
https://www.sciencedirect.com/science/article/pii/S2666991921001123?via%3Dihub
13. Leonardi AJ, Proenca RB. Akt-Fas to Quell Aberrant T Cell
Differentiation and Apoptosis in Covid-19. Front. Immunol. December 21,
2020
https://www.frontiersin.org/articles/10.3389/fimmu.2020.600405/full
14. COVID-19 Response Reporting. Mass.gov. Jan. 19, 2023.
https://www.mass.gov/info-details/covid-19-response-reporting#covid-19-state-facility-report-
15. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of
post-acute sequelae of COVID-19. Nature. April 2021.
https://www.nature.com/articles/s41586-021-03553-9
16. Mina MJ, Kula T, Leng Y. et al. Measles virus infection diminishes
preexisting antibodies that offer protection from other pathogens.
Science. Nov. 1, 2019.
https://www.science.org/doi/10.1126/science.aay6485
17. Statens Serum Institut - RS-virus. Jan. 1, 2023.
https://experience.arcgis.com/experience/220fef27d07d438889d651cc2e00076c/page/RS-virus/
18. Current weekly report on RSV. The Public Health Agency of Sweden.
https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/statistik-a-o/sjukdomsstatistik/rsv-veckorapporter/aktuell-veckorapport-om-rsv/
19. Sweden’s Pandemic Experiment. Edited BySigurd Bergmann, Martin
Lindström Dec. 18, 2022. https://doi.org/10.4324/9781003289364
https://www.taylorfrancis.com/books/oa-edit/10.4324/9781003289364/sweden-pandemic-experiment-sigurd-bergmann-martin-lindstr%C3%B6m